SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses-Reference-Cited by-同舟云学术

SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses

Published:2023-06 Issue:2 Volume:3 Page:100149
ISSN:2667-0380
Container-title:Journal of Clinical Virology Plus
language:en
Short-container-title:Journal of Clinical Virology Plus

Author:

Mazzetti Paola,Spezia Pietro Giorgio,Capria Anna-Lisa,Freer Giulia,Sidoti Maria,Costarelli Silvia,Cara Alice,Rosellini Alfredo,Frateschi Susi,Moscato Giovanna,Franconi Iacopo,Curcio Michele,Vatteroni Maria Linda,Lai Michele,Quaranta Paola,Focosi Daniele,Sani Spartaco,Pistello Mauro

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference12 articles.

1. SARS-CoV-2 phylogenetic analysis, lazio region, Italy, February-March 2020;Bartolini;Emerging Infect. Dis.,2020

2. Sotrovimab drives SARS-CoV-2 Omicron variant evolution in immunocompromised patients;Destras;Lancet Microbe,2022

3. Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: a series of three cases;Focosi;J. Clin. Virol. Plus,2022

4. Resistance mutations in SARS-CoV-2 Delta variant after sotrovimab use;Rockett;N. Engl. J. Med.,2021

5. Resistance mutations in SARS-CoV-2 Omicron variant in patients treated with sotrovimab;Vellas;Clin. Microbiol. Infect.,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal analysis of genomic mutations in SARS-CoV-2 isolates from persistent COVID-19 patient;iScience;2024-05

2. SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs;Cell Chemical Biology;2024-04

3. Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants;Viruses;2024-01-31

4. Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment;Drug Resistance Updates;2023-11